Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients.
AUTOR(ES)
Sorensen, R U
RESUMO
Lymphocyte responses to the mitogens phytohemagglutinin and concanavalin A and to Streptococcus pyogenes, Staphylococcus aureus, Haemophilus influenzae, and Pseudomonas aeruginosa were evaluated in patients with cystic fibrosis and in normal individuals. Lymphocyte proliferation in vitro was stimulated by gentamicin-killed whole bacteria, and the proliferative response was measured by [3H]thymidine incorporation. The in vitro lymphocyte responses to antibiotic-killed bacterial reached maximum thymidine incorporation after 5 days in culture and followed a unimodal dose-response curve for each of the bacteria studied. A significant specific incapacity to respond to P. aeruginosa was detected in cystic fibrosis patients with advanced clinical disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=421296Documentos Relacionados
- Defective cellular immunity to gram-negative bacteria in cystic fibrosis patients.
- In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
- Antibodies to cell envelope proteins of Pseudomonas aeruginosa in cystic fibrosis patients.
- Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
- Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.
